Developer of drugs for tuberculosis. The company develops drugs using a molecular-genetic platform for treating drug-resistant tuberculosis through semiconductor sequencing.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Grant | 02-Dec-2014 | $424K | 00000 | Completed | Startup | |
1. Angel (individual) | 02-Dec-2014 | 00000 | 00000 | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Skolkovo Foundation | Limited Partner | 000 0000 | 000000 0 |